BioPartnering China 1.0 in Conjunction with BioEco 2009 Conference 25-28 June
19.5.2009 15:11:51 CEST | Business Wire | Press release
4 Day Networking Event at the Binhai International Convention Centre, Tianjin, China
BioPartnering China 1.0 in Conjunction with BioEco 2009 Conference 25-28 June
BioPartnering China 1.0 (BPC) produced by Technology Vision Group LLC (TVG), in conjunction with the International Conference for Bioeconomy (BioEco) will provide international and Chinese life science delegates a 4 day, 2 event, 1 location opportunity to meet the critical players in the growing Chinese life science market. China's biotech industry is evolving rapidly, presenting international life science companies with valuable partnering opportunities. Substantial Chinese government funding is driving innovation, attracting scientific talent, and building the foundation to support international partnerships. The key to success for US companies in forging relationships in China is understanding the unique opportunities and challenges the China biotech sector presents.
TVG Has Built a Critical Network in This Emerging Market
This network supports US companies as they navigate the Chinese market. Building on the successful model of BioPartnering Europe and BioPartnering North America, TVG now brings you BPC, which will bring together Chinese and US entrepreneurs, venture capitalists, life science companies, and strategic partners you need to access in this vast, rapidly growing market.
BPC Launches on 25 June 2009 in Tianjin , an important economic center with significant government funding dedicated to biotech development. BPC delegates are automatically welcomed to the BioEco Conference on 26-28 June.
BioEco 2009 is the most influential professional exhibition and technical exchange platform in the pharmaceutical technology and life science areas in China, playing an important role as a bridge connecting government, industry, academic research, funding and services, historically bringing in more than 80,000 professional visitors. BPC is your opportunity to set up one-to-one meetings the day before BioEco, through the power of biopartnering.com networking software.
China's Economic Stimulus Package is Driving Significant Funding
The Chinese government has established national ministries and departments focused on this sector, most notably the Ministry of Science and Technology (MOST) and its life science division, the China National Center for Biotechnology Development (CNCBD).
TVG is creating an environment in which the world’s best life science companies can meet their Chinese counterparts to do business together, by collaborating with the China National Center for Biotechnology Development (CNCBD) in Beijing, which is a Department of the Ministry of Science and Technology (MOST), the Tianjin Municipal Science and Technology Commission (TSTC), the European Federation of Biotechnology (EFB), and BayHelix Group, an elite organization of Chinese life science business leaders.
A representative from CNCBD said, “We hope more and more foreign companies and friends come to China to accelerate biotechnology and industry development in China. We believe, through our cooperation with EFB, TSTC, TVG and other related institutions around the world, we can not only make BioEco 2009 and BioPartnering China successful and fruitful, but also provide greater cooperation platforms in China to biotech companies and friends in the rest of the biotech world.”
At regional levels, cities such as Shanghai, Beijing, Tianjin, and others have created initiatives to fund the growth of science parks and other economic development incentives. With 1.3 billion people, China must use biotechnology for various applications such as human, animal and plant health, food, materials, energy and other industrial uses. In fact, China has focused its attention on all aspects of what is termed the “bioeconomy” or that aspect of total economic activity in China, and globally, which allows national leadership to address key challenges to its sustainability in the 21st century. With a unique combination of huge government surpluses, focused guidance from the top, plenty of private sector capital, a skilled talent-base and entrepreneurs, China is quickly emerging as a rising star.
Europe Recognizes the Opportunity for Life Science Companies in China
Jens Sundbye, Board member of EFB remarked, “We have a long standing close collaboration with CNCBD and Chinese life science companies and organizations through joint life science programs and technology transfer activities throughout China. We are honored that CNCBD/MOST has invited the partners for collaboration and creation of the life science Olympics. The partners are experienced drivers of the global life science value train and invite the world to come to China and experience what China can offer.”
Register now for the combined BPC and BioEco, and take part in 4 days of networking opportunities with life science stakeholders, 25-28 June, in Tianjin, China.
For more details and information on BPC & BioEco, please visit the BPC website at http://www.techvision.com/bpc .
To sponsor BPC, please contact DeShonne Rushton at drushton@techvision.com .
To view the BPC and BioEco 2009 Program, please visit http://www.techvision.com/bpc/program .
Companies registered to attend and support BPC :
39 Panlabs, Inc.; AstraZeneca Innovation Centre China; BayHelix Group; Bio Alberta; BioCentury BioIndustry Association; BioMelbourne Network; Bioon; BIOTECanada; Biotech Pharmaceutical Co., Ltd.; BioWorld; Business Wire; Charles River China; China National Center for Biotechnology Development (CNCBD); China Pharmaceutical News; CoSci Med-Tech Co.,Ltd.; Daiichi Sankyo Co., Ltd.; Daiichi Sankyo Research Institute; Department of the Ministry of Science and Technology (MOST); EFB/BiomedicoForum; Eli Lilly Global R&D, China; European Federation of Biotechnology (EFB); FierceBiotech; HBM BioMed China Partners Limited; Health Sohu Hutchison MediPharma; Institute of Biophysics; Life Sciences British Columbia; Medicine Economic News; Nature Publishing Group; NewSummit Biopharma; Perkins Coie LLP; Pharma-GPS, LLC; PharmaLegacy Laboratories; Reed Sinopharm Exhibitions; Sanofi Aventis; Shanghai Clinical Research Center; Shenyang Xiehe Group Co., Ltd.; Technology Vision Group LLC; Tianjin Municipal Science and Technology Commission (TSTC); Xian-Janssen Pharmaceutical Ltd.; Zoomedia
BioEco 2009 exhibitors:
All Association Guangzhou Trading Co., Ltd.; Aspen can come to Beijing Bio-engineering Co., Ltd.; Beijing Xin Wei Yao Advertising Co Ltd; Bio-engineering Co., Ltd. Zhengzhou; Business Network Bao Sheng Zhejiang Co., Ltd.; Changchun City, New Institute of Biochemistry; Chengdu Pharmaceutical Co., Ltd.; Daytona International Group Pharmaceutical Co., Ltd. Xi'an North; Ding Crane Pharmaceutical Co., Ltd., Jilin Province; Ding Ming Yunnan Pharmaceutical Co., Ltd.; Fukang biopharmaceutical Beijing Hui Technology Co., Ltd.; Fuzhou, Fujian Hai Pharmaceutical Co., Ltd.; Grandeur Terrace Jilin Pharmaceutical Co., Ltd.; Guangdong Lingnan Pharmaceutical Co., Ltd.; Guangyuan, Chengdu, Sichuan Pharmaceutical Co., Ltd.; Hainan in the joint of the pharmaceutical industry Co., Ltd.; Hampson HP Hainan Pharmaceutical Biotechnology Co., Ltd.; Hangzhou Jide Biological Technology Co., Ltd.; Hanlin Yuan Beijing Times Technology Co., Ltd.; Heilongjiang Province arzneimittel Wanjin; Houston Sichuan Pharmaceutical Co., Ltd.; Huairen Tianjin Pharmaceutical Co., Ltd.; Hubei Hua Sheng Pharmaceutical Co., Ltd.; Hubei Pharmaceutical Co., Ltd. Xin Ye; Hubei Tian Xin Pharmaceutical Co., Ltd.; Hui Xian Hui Pharmaceutical Co., Ltd.; Hunan Fabory Co., Ltd.; Imacon days Hubei Pharmaceutical Co., Ltd.; Jia Kang Hunan Medicine Co., Ltd.; Jiangsu million high-Pharmaceutical Co., Ltd.; Jilin Chinese Medicine Co., Ltd.; Jilin Pharmaceutical Co., Ltd.; Jilin Pharmaceutical Co., Ltd. Dual disabilities; Jilin Pharmaceutical Co., Ltd. Lihua Sales; Jinan Limin Pharmaceutical Co., Ltd.; Joint Group of the Great Wall Shanghai Industrial Pharmaceutical Co., Ltd.; Kazakhstan jiamusi Chinese Hi-Tech Co., Ltd.; Lihua Pharmaceutical Co., Ltd., Jilin Province; Malaysia Shenyang Pharmaceutical Co., Ltd.; Meno Hainan Pharmaceutical Co., Ltd.; Nanjing million Chuan Hua Tuo Chinese Medicine Co., Ltd.; Nanjing Pharmaceutical Technology Co., Ltd. according to Novozymes; Pacific Pharmaceutical Co., Ltd. Fujian; Pa-hang, Guizhou Pharmaceutical Co., Ltd.; Pharmaceutical Co., Ltd. Changchun Fuchun; Pharmaceutical Co., Ltd. Hebei Hong; Pharmaceutical Co., Ltd. Jiangsu licensing morning; Pharmaceutical Co., Ltd. Jinan letter and Culture; Pharmaceutical Co., Ltd. Liaoning Kangtai; Pharmaceutical Co., Ltd. Shandong Huayang; Pharmaceutical Co., Ltd. Shenzhen, Yongxiang; Pharmaceutical Co., Ltd. Yantai Zhengfang; Qi Fang Pharmaceutical Co., Ltd. Guangdong; Renhe Pharmaceutical Co., Ltd.; Roth, Guangdong Pharmaceutical Co., Ltd.; SECCO Hainan Pharmaceutical Co., Ltd.; Shandong Biochemical Pharmaceutical Co., Ltd. Business Alliance; Shandong Pharmaceutical Technology Co., Ltd. Seth Saike; Shanxi Yellow River Chinese Medicine Co., Ltd.; Shijiazhuang Pharmaceutical Technology Co., Ltd.; Sichuan Pharmaceutical Co., Ltd.; Songhai pharmaceutical factory in Nanchang, Jiangxi; Tangshan Jing Zhong Shan Pharmaceutical Co., Ltd.; Tianbao Guangxi, China Pharmaceutical Co., Ltd.; Tianjin Jin-Hua Pharmaceutical Factory; Tianjin Pharmaceutical Co., Ltd.; Tianjin Shi Ji Biological Engineering Co., Ltd.; Tonghua Tailin Drugs Sales Co., Ltd.; Wang Pharmaceutical Co., Ltd. Shandong; Wang Pharmaceutical Co., Ltd. Shandong; Yang Xin Zhu, Hangzhou Pharmaceutical Co., Ltd.; Yung shin Guangzhou Pharmaceutical Co., Ltd.; Yunnan Pharmaceutical Co., Ltd. Yicheng; Zhejiang Medicine Co., Ltd.; Zhejiang Pharmaceutical Co., Ltd. for the Culture and Sport; Zhuhai Bao Jian An Pharmaceutical Co., Ltd.; Zibo Development Zone, Asia Pharmaceutical Co., Ltd.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Contact:
For BioPartnering China
Dr. Robert Lee Kilpatrick
Partner,
Technology Vision Group LLC
Tel: +1 8314644230
Email: rlkilpatrick@techvision.com
or
For
BioEco 2009
Organized by
Qiang JIN ; Jing Ma ; Xiaomeng Su
Tianjin
Institute of Scientific and Technical Information
Tel:
8622-23519125 ; 8622-23330582;
8622-23519311 ; 8622-23378753
Fax:
8622-23330582 ; 8622-23378753
E-mail: bio@tjst.net
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 08:00:00 CEST | Press release
From dating apps to financial details, respondents report seeing a wide range of highly personal information on others' screens 56% of people admit to having looked at strangers’ phone screens accidentally, whereas 24% have done so out of curiosity. 57% identify public transport as the most likely place to notice someone else's screen. While 48%* feel confident they can keep their phone activity private when using it in crowded places, another 52%** acknowledge it is easy to see someone’s screen who is next to you in a public place without trying to look. 33% say they have seen personal content on a stranger’s phone in public. Some smartphone users who have looked at a stranger’s phone screen in public ignore and continue what they were doing (28%) or look away immediately (27%), but others (7%) admit to continuing to look discreetly. The new Samsung Galaxy S26 Privacy Display1 limits side-angle viewing of your screen to protect your privacy in any setting. As millions of Europeans2 ge
RevolKa Reimagines Antibody Engineering with "RevoAb®"1.4.2026 06:30:00 CEST | Press release
A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering Engine RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allo
Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press release
Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales,
bet365 Partners with TestMu AI to Accelerate Global Release Velocity with Agentic AI Quality Engineering31.3.2026 19:01:00 CEST | Press release
Streamlines Hillside Technology testing across browsers and mobile devices while supporting rapid expansion into regulated markets. TestMu AI (Formerly LambdaTest), the world's first full-stack Agentic AI Quality Engineering platform, today announced that Hillside Technology Limited, the technology powerhouse behind global online gambling leader bet365, has adopted its platform to unify software testing and support hundreds of weekly production releases. The global online gaming industry is currently experiencing a massive shift, with the market projected to exceed $150 billion by 2030. As mobile gaming becomes the primary touchpoint for users, the technical complexity of delivering a seamless, low-latency experience has grown exponentially. For industry giants like bet365, the need to validate software across an infinite matrix of hardware, screen resolutions, and OS versions is a mission-critical requirement. This partnership ensures that, as gaming becomes more mobile-centric, bet36
IFF Secures First Heart Health Claim for Soy Protein in Australia and New Zealand31.3.2026 16:00:00 CEST | Press release
Regulatory milestone opens heart health growth opportunities for food and beverage manufacturers IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and health & biosciences announced today that a new heart health claim for isolated soy protein has been accepted by the Food Standards Australia New Zealand (FSANZ). The approval enables food and beverage manufacturers in Australia and New Zealand to link soy protein consumption with healthy blood cholesterol levels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330523416/en/ First heart health claim approved for soy protein in Australia and New Zealand. “For decades, IFF has invested in the science behind soy protein and its role in supporting cardiovascular health,” said Tony Andrew, vice president of protein solutions for IFF Food Ingredients. “This approved claim validates years of rigorous research and collaboration. With our deep expertise in ing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom